Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
581.51 USD | +0.61% | -1.43% | +10.42% |
09-10 | Health Care Up on Defensive Bias -- Health Care Roundup | DJ |
09-10 | UnitedHealth Group to Exclude AbbVie's Humira From Some US Drug Reimbursement Lists | MT |
Projected Income Statement: UnitedHealth Group Inc.
Fiscal Period: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 242,155 | 257,141 | 287,597 | 324,162 | 371,622 | 399,372 | 430,641 | 462,390 |
Change | - | 6.19% | 11.84% | 12.71% | 14.64% | 7.47% | 7.83% | 7.37% |
EBITDA 1 | 22,405 | 25,296 | 27,073 | 31,835 | 36,330 | 38,691 | 43,612 | 48,064 |
Change | - | 12.9% | 7.02% | 17.59% | 14.12% | 6.5% | 12.72% | 10.21% |
EBIT 1 | 19,685 | 22,405 | 23,970 | 28,435 | 32,358 | 33,298 | 39,142 | 43,461 |
Change | - | 13.82% | 6.99% | 18.63% | 13.8% | 2.91% | 17.55% | 11.03% |
Interest Paid 1 | -1,704 | -1,663 | -1,660 | -2,092 | -3,246 | -3,683 | -3,778 | -3,874 |
Earnings before Tax (EBT) 1 | 17,981 | 20,742 | 22,310 | 26,343 | 29,112 | 26,995 | 35,253 | 39,678 |
Change | - | 15.36% | 7.56% | 18.08% | 10.51% | -7.27% | 30.59% | 12.55% |
Net income 1 | 13,839 | 15,403 | 17,285 | 20,120 | 22,381 | 15,051 | 27,024 | 30,093 |
Change | - | 11.3% | 12.22% | 16.4% | 11.24% | -32.75% | 79.55% | 11.36% |
Announcement Date | 15/01/20 | 20/01/21 | 19/01/22 | 13/01/23 | 12/01/24 | - | - | - |
Forecast Balance Sheet: UnitedHealth Group Inc.
Fiscal Period: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 29,693 | 26,546 | 22,096 | 18,927 | 32,909 | 41,325 | 23,604 | -3,616 |
Change | - | -10.6% | -16.76% | -14.34% | 73.87% | 25.57% | -42.88% | -115.32% |
Announcement Date | 15/01/20 | 20/01/21 | 19/01/22 | 13/01/23 | 12/01/24 | - | - | - |
Cash Flow Forecast: UnitedHealth Group Inc.
Fiscal Period: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 2,071 | 2,051 | 2,454 | 2,802 | 3,386 | 3,557 | 3,957 | 4,217 |
Change | - | -0.97% | 19.65% | 14.18% | 20.84% | 5.05% | 11.25% | 6.57% |
Free Cash Flow (FCF) 1 | 16,392 | 20,123 | 19,889 | 23,404 | 25,682 | 25,612 | 30,919 | 33,190 |
Change | - | 22.76% | -1.16% | 17.67% | 9.73% | -0.27% | 20.72% | 7.34% |
Announcement Date | 15/01/20 | 20/01/21 | 19/01/22 | 13/01/23 | 12/01/24 | - | - | - |
Forecast Financial Ratios: UnitedHealth Group Inc.
Fiscal Period: Dezember | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 9.25% | 9.84% | 9.41% | 9.82% | 9.78% | 9.69% | 10.13% | 10.39% |
EBIT Margin (%) | 8.13% | 8.71% | 8.33% | 8.77% | 8.71% | 8.34% | 9.09% | 9.4% |
EBT Margin (%) | 7.43% | 8.07% | 7.76% | 8.13% | 7.83% | 6.76% | 8.19% | 8.58% |
Net margin (%) | 5.71% | 5.99% | 6.01% | 6.21% | 6.02% | 3.77% | 6.28% | 6.51% |
FCF margin (%) | 6.77% | 7.83% | 6.92% | 7.22% | 6.91% | 6.41% | 7.18% | 7.18% |
FCF / Net Income (%) | 118.45% | 130.64% | 115.07% | 116.32% | 114.75% | 170.17% | 114.41% | 110.29% |
Profitability | ||||||||
ROA | 8.48% | 8.3% | 8.44% | 8.79% | 8.62% | 6.98% | 8.96% | 9.32% |
ROE | 25.7% | 24.9% | 24.11% | 25.71% | 26.8% | 26.07% | 26.62% | 26.3% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 1.33x | 1.05x | 0.82x | 0.59x | 0.91x | 1.07x | 0.54x | - |
Debt / Free cash flow | 1.81x | 1.32x | 1.11x | 0.81x | 1.28x | 1.61x | 0.76x | - |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 0.86% | 0.8% | 0.85% | 0.86% | 0.91% | 0.89% | 0.92% | 0.91% |
CAPEX / EBITDA (%) | 9.24% | 8.11% | 9.06% | 8.8% | 9.32% | 9.19% | 9.07% | 8.77% |
CAPEX / FCF (%) | 12.63% | 10.19% | 12.34% | 11.97% | 13.18% | 13.89% | 12.8% | 12.71% |
Items per share | ||||||||
Cash flow per share 1 | 19.11 | 23.07 | 23.37 | 27.59 | 30.99 | 37.54 | 37.67 | 41.69 |
Change | - | 20.74% | 1.29% | 18.03% | 12.34% | 21.13% | 0.36% | 10.66% |
Dividend per Share 1 | 4.14 | 4.83 | 5.6 | 6.4 | 7.29 | 7.944 | 8.928 | 9.937 |
Change | - | 16.67% | 15.94% | 14.29% | 13.91% | 8.97% | 12.38% | 11.31% |
Book Value Per Share 1 | 60.77 | 68.8 | 80 | 85.74 | 96.06 | 106.1 | 122 | 140.1 |
Change | - | 13.21% | 16.28% | 7.17% | 12.04% | 10.46% | 15% | 14.78% |
EPS 1 | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 | 16.23 | 29.77 | 33.69 |
Change | - | 11.86% | 12.79% | 17.15% | 12.65% | -31.96% | 83.41% | 13.14% |
Nbr of stocks (in thousands) | 947,415 | 948,821 | 941,851 | 934,349 | 924,925 | 923,418 | 923,418 | 923,418 |
Announcement Date | 15/01/20 | 20/01/21 | 19/01/22 | 13/01/23 | 12/01/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
P/E ratio | 35.6x | 19.4x |
PBR | 5.45x | 4.74x |
EV / Sales | 1.44x | 1.29x |
Yield | 1.37% | 1.54% |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
- Stock Market
- Equities
- UNH Stock
- Financials UnitedHealth Group Inc.
MarketScreener is also available in this country: United States.
Switch edition